Multidisciplinary approach for evaluation of neurocutaneous disorders in children in Sohag University Hospital, Upper Egypt  by Sadek, Abdelrahim A. et al.
The Egyptian Journal of Medical Human Genetics (2015) 16, 149–157HO ST E D  BY
Ain Shams University
The Egyptian Journal of Medical Human Genetics
www.ejmhg.eg.net
www.sciencedirect.comORIGINAL ARTICLEMultidisciplinary approach for evaluation of
neurocutaneous disorders in children in Sohag
University Hospital, Upper Egypt* Corresponding author.
Peer review under responsibility of Ain Shams University.
http://dx.doi.org/10.1016/j.ejmhg.2015.02.003
1110-8630  2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Ain Shams University.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Abdelrahim A. Sadek a,*, Sahr N. Abdel Samad a, Mohammed A. Bakheet a,
Ismail A.A. Hassan a, Wafaa M. Abd El-Mageed b, Ahmed M. Emam ca Pediatric Department, Sohag University, Sohag, Egypt
b Dermatology Department, Sohag University, Sohag, Egypt
c Phoniatric Unit, ENT Department, Sohag University, Sohag, EgyptReceived 23 December 2014; accepted 4 February 2015
Available online 5 March 2015KEYWORDS
Neurocutaneous disorders;
Tuberous sclerosis;
Seizures;
Cerebral calciﬁcations;
Infantile spasms;
AutismAbstract Background: Neurocutaneous syndromes (NCS) are a broad term for a group of neuro-
logic disorders that involve the nervous system and the skin. The most common examples are neu-
roﬁbromatosis type 1 (NF-1) and type 2 (NF-2), tuberous sclerosis (TS), Sturge–Weber syndrome
(SWS), ataxia telangiectasia (AT), and Von Hippel Lindau disease (VHL). These disorders are char-
acterized clinically by neurological manifestations such as convulsions, mental retardation and
learning disabilities in addition to cutaneous manifestations, and lastly tubers (benign growths
found in different organs of the body).
Aim of the study: This study aimed to identify clinical, imaging, and neurophysiological proﬁles
of neurocutaneous disorders. Children presented to the Pediatric neurology and Dermatology clin-
ics, Sohag University Hospital who fulﬁlled the criteria for diagnosis of speciﬁc neurocutaneous
syndromes were eligible for this study.
Patients and methods: All studied patients were subjected to thorough clinical history, full clin-
ical examination, developmental assessment, and dermatological examination. Computed tomogra-
phy of the brain (CT) and electroencephalography (EEG), ophthalmic, and phoniatric evaluation
were also done for all children. Echocardiography was done for only twenty children.
Results: During the period of the study we diagnosed 27 cases with neurocutaneous disorders,
tuberous sclerosis represented the majority of cases as it was detected in 12 cases (44.45%). The
main complaint was convulsions in 19 cases (70.37%), whereas skin pigmentation was detected
in 18 cases (66.66%). Developmental assessment showed that global developmental delay was
found in 20 cases (74%). CT of the brain showed that 15 cases (55.55%) had intracranial calciﬁca-
tions and abnormal EEG ﬁndings were detected in 23 cases (85.2%). 85% of the studied children
had various degrees of mental retardation. Echocardiography showed that three cases (15%) had
ventricular wall tumor mostly rhabdomyoma.
150 A.A. Sadek et al.Conclusion: Neurocutaneous disorders had multiple clinical presentations and required a team
work approach including various specialties in their evaluation and management.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Ain Shams University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Neurocutaneous syndromes are a broad term for a group of
neurologic disorders that involve the nervous system and the
skin. These syndromes are due to defects in differentiation of
the primitive ectoderm and usually life-long conditions that
can predispose to malignancies. The most common examples
are neuroﬁbromatosis type 1 (NF-1) and neuroﬁbromatosis
type 2 (NF-2), tuberous sclerosis (TS), Sturge–Weber syn-
drome (SWS), ataxia telangiectasia (AT), and Von Hippel
Lindau disease (VHL) [1]. Neurocutaneous disorders are
relatively common and could be seen in different societies with
different incidences for example, NF-1 affects one in every
4000 births while NF-2 affects one in every 60,000 births in
the United Kingdom [2] while in other countries NF-1 has a
birth incidence of 1 in 2500 to 1 in 3000 [3,4]. Tuberous sclero-
sis affects one every 6000–9000 births and nearly one million
people worldwide are known to have tuberous sclerosis [5].
Sturge–Weber syndrome, ataxia telangiectasia and the Von
Hippel Lindau disease are rare disorders.
These disorders are characterized clinically by neurological
manifestations as convulsions, mental retardation and learning
disabilities [6], in addition to cutaneous manifestations includ-
ing cafe´ au lait patches, port-wine stain (facial birth mark cov-
ering one upper eyelid and forehead), telangiectasia (tiny red
spider-like blood vessels), and tubers (benign growths found
on different organs as brain, eyes, heart, skin, kidneys and
lungs) [6,7]. These manifestations are present in various combi-
nations according to the type of syndrome allowing clinical
diagnosis in most of the cases.
Clinical features required for diagnosis of NF-1 are; (1) one
to six or more cafe´-au-lait spots over 5 mm in greatest diameter
in pre-pubertal individuals and over 15 mm in greatest dia-
meter in post-pubertal individuals, (2) two or more neuroﬁbro-
mas of any type or one plexiform neuroﬁbroma, (3) Freckling
in the axillary or inguinal regions, (4) optic glioma, (5) two or
more lisch nodules (iris hamartomas), (6) osseous lesions such
as sphenoid dysplasia or thinning of the long bone cortex with
or without pseudoarthrosis, (7) ﬁrst degree relative affection (-
parent, sibling, or offspring) with NF-1 by the above criteria
with discovered mutations of the NF-1 gene, which is located
at chromosome 17q11.2. Two of these seven ‘‘cardinal clinical
features’’ are required for positive diagnosis [8].
Clinical diagnostic criteria for TS include 11 major features
and six minor features. Major features include: hypomelanotic
macules (P3, at least ﬁve-mm diameter), angioﬁbromas (P3),
ungual ﬁbromas (P2), shagreen patch, multiple retinal hamar-
tomas, cortical dysplasias (includes tubers and cerebral white
matter radial migration lines), subependymal nodules,
subependymal giant cell astrocytoma, cardiac rhabdomyoma,
lymphangioleiomyomatosis (LAM), and angiomyolipomas
(P2). Minor features include; ‘‘confetti’’ skin lesions, dental
enamel pits (>3), intraoral ﬁbromas (P2), retinal achromic
patch, multiple renal cysts, and nonrenal hamartomas.Deﬁnite diagnosis should include two major features or one
major feature with Ptwo minor features and possible diagno-
sis: either one major feature or Ptwo minor features [9].
Sturge–Weber syndrome (SWS) is a congenital non inherit-
ed neurocutaneous disorder. It is characterized by cutaneous
manifestations, neurological abnormalities, and eye affection
[10]. Xeroderma pigmentosum (XP) is a rare, autosomal reces-
sive disorder. There is an impairment of skin ability to repair
damage from ultraviolet light, leading to early skin changes,
and eye damage [11].
Early diagnosis of these disorders is very important as it
allows early treatment, proper follow up and genetic counsel-
ing. This requires the integrated work of pediatricians, derma-
tologists, ophthalmologists and other specialties to make
appropriate diagnosis and management strategy. To the best
of our knowledge a few studies were done in Upper Egypt to
clarify this topic so our aim was to identify clinical, imaging,
and neurophysiological proﬁles of neurocutaneous disorders
in Sohag, Upper Egypt.2. Patients and methods
2.1. Study design
This is an observational hospital based study, done in the
Pediatric neurology and Dermatology clinics at the Sohag
University Hospital, Upper Egypt, during the period from
December 2012 through November 2013. All children from
birth up to 15 years old who fulﬁlled the criteria for diagnosis
of speciﬁc neurocutaneous syndromes were eligible for this
study. Informed consent of the parents of the children was tak-
en to conduct this research in addition to the approval of the
Faculty of Medicine, Sohag University Ethics committee.
The work has been carried out in accordance with The Code
of Ethics of The World Medical Association (Declaration of
Helsinki) for experiments on humans.
2.2. Methods
All studied patients were subjected to thorough clinical history
including detailed history of the presenting symptoms like sei-
zures and developmental history. Autistic symptoms, hyperac-
tivity symptoms, and a family history of similar conditions
such as presence of epilepsy, mental retardation or global
developmental delay were also clariﬁed.
Full clinical examination (general, systematic, and detailed
neurological examinations), developmental assessment, and
dermatological examination were done. Computed tomogra-
phy of the brain (CT) and electroencephalography (EEG) were
done for all patients. Echocardiography was done for only 20
children. All patients were referred to the Phoniatric Unit and
were subjected to language evaluation as well as assessment of
passive and active vocabulary. Also evaluation of the autistic
Table 2 Seizure characteristics in the studied children.
Variable N= 19 Percentages (%)
Age of onset
1 month–1 year 11 57.89
1year–5year 5 26.32
5year–12year 3 15.79
Type of seizures
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criteria for autism [12], and Childhood Autism Rating Scale
(CARS) was done. The degree of autistic disorders was set
as 30 serving as the diagnostic point for autism [13].
Mentality was assessed by Vineland Adaptive Behavior
Scales [14], and Stanford–Binet Intelligence Scales [15].
Ophthalmological and fundus examination were done to detect
any eye affection.
3. Results
3.1. Descriptive data of the studied patients
During the study period, 27 children were diagnosed as having
different types of neurocutaneous syndromes by clinical
examination and neuroradiological studies (CT Brain). The
mean age of the whole studied group was 5.27 ± 4.11 years.
Fifteen children (56%) were males and 12 (44%) were females.
It was found that tuberous sclerosis cases were 12 cases
(44.45%) constituting the majority of the cases followed by
neuroﬁbromatosis, and xeroderma pigmentosum were detected
in four cases (14.82%) for each. Sturge–Weber syndrome cases
were detected in three cases (11.11%) and lastly incontinentia
pigmenti and hypomelanosis of ito were detected in two cases
(7.40%) for each (Table 1).
3.2. Clinical features
The main complaint was convulsions which was detected in 19
children (70.37%) whereas skin pigmentations were detected in
18 cases (66.66%), delayed motor development was detected in
6 cases (22.22%), and autistic features were detected in four
children (14.8%) (Fig. 1).
As regards seizures, eleven children (58%) started to expe-
rience seizures at the age of 1 month–1 year. Twelve childrenTable 1 Distribution of neurocutaneous syndromes.
Type No. of patients Percentage (%)
Tuberous sclerosis 12 44.45
Neuroﬁbromatosis 4 14.81
Xeroderma pigmentosa (XP) 4 14.81
Sturge–Weber syndrome (SWS) 3 11.11
Incontenentia pigmenti (IP) 2 7.41
Hypomelanosis of ito (HI) 2 7.41
Convulsions
Dermatological problems
Delayed motor 
development 
Ausc features
Global developmental 
delay 
Figure 1 Main complaint in the studied children.(63%) had generalized seizures including the 6 children (tuber-
ous sclerosis cases) who had infantile spasms, and seven chil-
dren (37%) who had focal seizures. Seizures were variable in
frequency where seven children (37%) experienced seizures
monthly, six children (36.5%) weekly. Response to treatment
varied as well, where seven children (37%) were controlled
and twelve children (63.15%) were not controlled (Table 2).
Delayed motor, language, and social development were
noted in 20 children (74%). This means that they had global
developmental delay. Eight children had sphincteric
abnormalities.
As regards general examinations; six children (22%) had
microcephaly, two children (7.4%) had dysmorphic features,
one patient (3.7%) had macrocephaly and one patient
(3.7%) had teeth abnormalities and alopecia.
Neurological examination of the studied children showed
that; 20 children (74.07%) had delayed speech, one child
(3.70%) had stuttering, and one child (3.70%) had a squint.
Seventeen children (63%) had generalized hypotonia and
hyperreﬂexia, and two children (7.4%) had hemi paresis, hypo-
tonia and hyperreﬂexia. Movement disorders were detected in
6 children; three children (11%) had ataxia, two children
(7.4%) had athetosis and one child (3.7%) had tremors
(Fig. 2).Generalized seizures 12 63.16
Partial (focal) seizures 7 36.84
Frequency of seizures
Monthly 7 36.84
Weekly 6 31.58
Daily 3 15.79
Very frequent (P3/day) 3 15.79
Response to treatment
Non controlled 12 63.15
Controlled 7 36.84
Ataxia
11% 
Athetosis
7% 
Tremors 
4%
Normal 
78% 
Figure 2 Movement disorders in the studied children.
152 A.A. Sadek et al.Dermatological examination showed that seven children
(25.93%) had asch-leaf macules, ﬁve children (18.52%) had
asch-leaf macules, shagreen patches and angioﬁbromatosis of
the face, and lastly four children (14.81%) had cafe´ au-lait
patches (Table 3 and Figs. 4–11).
3.3. Ophthalmological and fundus examination
By ophthalmological and fundus examination; it was found
that 22 children (81.4%) had normal fundus examination,Table 3 Dermatological manifestations of the studied
children.
Dermatological examination Number Percentages (%)
Asch-leaf macules 7 (25.93)
Asch-leaf macules, shagreen patches,
angioﬁbromatosis of the face
5 (18.52)
Cafe´ au-lait patches 4 (14.81)
Axillary, inguinal freckles 4 (14.81)
Sun exposed freckles 3 11.11
Port-wine stain 3 11.11
Bizzar shaped hypo pigmentations 2 (7.40)
Bizzar shaped hyper pigmentations 2 (7.40)
15
37
44
4% 
Dull Normal (80-89)
Mild Mental Retardaon 
(70-79) 
Moderate Mental 
Retardaon (50-69) 
Severe Mental 
Retardaon (20-49%)
Figure 3 IQ ﬁndings in the studied children.
Figure 4 Ash-leave macules and shagreen patch in the back in a
child with tuberous sclerosis.
Figure 5 Angioﬁbromatosis of the face in a child having
tuberous sclerosis.
Figure 6 Cafe´ au lait patches in neuroﬁbromatosis type 1 child.
Figure 7 Axillary freckles in a child had neuroﬁbromatosis type
1.two children (7.4%) had papilledema with optic atrophy and
retinopathy. Iris lisch nodules were detected in one case
(3.75%), pale optic disc in one case, and high intraocular pres-
sure (IOP) in one case (3.75%).
Figure 8 Port-wine stain in a girl having the Sturge–Weber
syndrome.
Figure 9 Freckles with hypo and hyper pigmentation in the face
in a girl with xeroderma pigmentosa.
Figure 10 Whorly pattern of hypo pigmentation in a child with
hypomelanosis of ito.
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CT brain was done to all studied children and showed that 12
children (44.44%) had multiple foci of calciﬁcations (scattered
or periventricular), and three children (11.11%) had serpentine
calciﬁcations. In one child with neuroﬁbromatosis there was a
brain tumor which correlates with astrocytoma and conﬁrmed
by magnetic resonance imaging (MRI) of the brain (Table 4
and Figs. 11–13).
3.5. EEG ﬁndings
EEG was done to all children and we found that nine children
(33.33%) had focal epileptic discharges, eight children
(29.62%) had generalized epileptic discharges, six children
(22.22%) had hypsarrhythmia, and four children (14.81%)
had normal EEG ﬁndings (Table 5).
3.6. IQ ﬁndings
Intelligence Quotient (IQ) assessment showed that 12 children
(44.4%) had moderate mental retardation (MR), ten children
(37%) had mild MR Fig. 3).
3.7. Echocardiography ﬁndings
Echocardiography was done to 20 children and revealed that
16 children (80%) had normal echo ﬁndings, three children
(15%) had a ventricular wall mass (mostly rhabdomyoma),
and one child (5%) had arrhythmia conﬁrmed by electrocar-
diography (ECG). Children with positive echocardiographic
ﬁndings were belonging to tuberous sclerosis complex group.
4. Discussion
Neurocutaneous syndromes are a group of disorders that lead
to the growth of tumors in various parts of the body including
the nervous system and skin. While some can be diagnosed at
birth; others do not produce symptoms until later in life.
Although neurocutaneous syndromes cannot be cured, treat-
ments can help to manage symptoms and any health problems
that occur [1].
The present study performed a clinical analysis and prospec-
tively collected the data of 27 children having NCS. The mean
age was 5.2 ± 4.11 years which was nearly similar to other stud-
ies [16,17], and lower than the results of Sun et al., study where
the mean age was 14.7 ± 10.5 years as their study included a
wide range of age 2 months–58 years [18]. In our study, neuro-
cutaneous disorders were slightly more common in males and
this agrees with the study of Purkait et al. [16].
In our study we found that the majority of the collected cas-
es were tuberous sclerosis (44.44%) followed by neuroﬁbro-
matosis type1 and xeroderma pigmentosum (XP). This was
in accordance to the study of Diaconu et al. [19], and in con-
trast to the results of Purkait et al., where NF-1 were the most
common [16].
In the present study the most common presentation of NCS
was convulsions in 70.37% of the studied children, this was
slightly lower than the result of Jo´z´wiak et al., where seizures
were recorded in 95% of the patients [20], and much higher
Figure 11 CT brain showed multiple cortical calciﬁcations in a child with tuberous sclerosis.
Table 4 CT brain ﬁndings in the studied children.
Variables Number Percent (%)
Multiple foci of calciﬁcations 6 (22.22)
Periventricular calciﬁcations 6 (22.22)
Serpentine calciﬁcations 3 (11.11)
Involutional changes 2 (7.41)
Hydrocephalus 2 (7.41)
White matter disease 1 (3.7)
Tumor (Astrocytoma) 1 (3.7)
Normal 6 (22.22)
154 A.A. Sadek et al.than the study of Diaconu et al., where convulsions were
detected in 39.13% of cases [19].This variation between studies
could be related to variations in the types of NCS.
The age of onset of convulsions was from 1 month to
12 years; this was similar to the study of Diaconu et al., where
the age of onset of seizures was 4 months to 15 years.
According to our study convulsions of most cases of NCS were
generalized seizures especially infantile spasms and frequentlyoccurred, this disagrees with Diaconu et al., study where the
commonest type of seizures was complex partial type, not fre-
quent. In our study patient’s response to treatment was vari-
able (good, partial and poor response), this was similar to
the study of Diaconu et al. [19]. In tuberous sclerosis, all chil-
dren were complaining of convulsions which were generalized
in 66.67% and focal in 33.33%, these results agree with the
study of So¨g˘u¨t et al. [17]. In 58.33% of TS cases, convulsions
started in the ﬁrst year of life and this agrees with the study of
Jo´z´wiak et al. [21]. Infantile spasms were observed in 50% of
TS cases and this was much higher than the study of
Jo´z´wiak et al., where infantile spasms were observed in 21%
of cases [21]. Epileptic discharges in EEG were detected in
91.7% and this was similar to Ulate-Campos et al., where
epileptic discharges in EEG were detected in 91% [22].
In tuberous sclerosis, cutaneous manifestations were the
most characteristic features which presented as initial manifes-
tations of the disease in 100% of cases and were helpful in ear-
ly diagnosis. We observed in our study that hypo pigmented
(Asch-leaf) macules were the most frequent sign as they could
be found in all children with TS, this was similar to other
Figure 12 MRI brain showed tumor correlated with astrocytoma.
Figure 13 Serpentine calciﬁcation in a child having Sturge–Weber syndrome.
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Table 5 EEG Findings in the studied children.
EEG ﬁndings Number Percentages (%)
Focal epileptic discharges 9 33.33
Generalized epileptic discharges 8 29.62
Hypsarrhythmia 6 22.22
Normal 4 14.81
156 A.A. Sadek et al.studies [21,22]. All the cases of NF-1 presented with one con-
sistent ﬁnding that was increasing number and size of cafe´ au
lait macules (CALM) and axillary or inguinal freckling, these
results agree with the study of Purkait et al. [16].
In our study, according to neurodevelopmental analysis of
the studied children, we found 74% of them had delayed
motor, social and language development, while by IQ testing
we found 85.2% had mental retardation (MR), this was much
higher than the results of Diaconu et al., study where only
21.73% of patients had mental retardation [19]. This could
be explained that only severe cases seek medical evaluation.
In tuberous sclerosis 33.33% of cases had autistic features.
The association of autism with TS is well known, many studies
agree with our ﬁndings and clarify this point [7,23–25].
CT brain in children with NCS revealed that 55.6% of the
patients had scattered, periventricular, and serpentine calciﬁca-
tions, this result was less than found in Sun et al., study where
brain calciﬁcations were observed in 70%. This was because
they studied only cases of TS [18]. Echocardiography showed
that 25% of children with tuberous sclerosis had a ventricular
wall mass (mostly rhabdomyoma); this was in accordance to
other studies [18,26].
By ophthalmological and fundus examination; it was found
that the majority had normal fundus (81.4%), other ﬁndings
were papilledema with optic atrophy and retinopathy, iris lisch
nodules, pale optic disc, and high Intraocular pressure (IOP).
These ophthalmological ﬁndings agree with other studies [27,28].
5. Conclusion
Neurocutaneous disorders had multiple clinical presentations;
tuberous sclerosis was the most frequent type of neurocuta-
neous disorders in our hospital. Epilepsy especially infantile
spasms was the commonest presentation for those children.
Language development and cognitive functions are signiﬁcant-
ly impaired in NCS so they should be assessed regularly for
those patients. Early diagnosis and follow up of these disorders
are important for appropriate management of seizures and
early detection of malignancy. This requires a team work
approach including pediatricians, neurologists, cardiologists,
ophthalmologists, dermatologists, phoniatrician, radiologists,
oncologists and other specialties in their evaluation and
management.
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